The DOI matches its Crossref record; 64 of the 64 references it cites were found in a registry or an index.
Genetics of melanoma predisposition
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cancer Epidemiology and Prevention
Breslow, L. (1997) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1997.03550210090050 · Cited by 1,424
Valverde, P., Healy, E., Jackson, I., Rees, J. L., & Thody, A. J. (1995) · Nature Genetics · doi:10.1038/ng1195-328 · Cited by 999
The p16INK4a/CDKN2A tumor suppressor and its relatives
Ruas, M., & Peters, G. (1998) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/s0304-419x(98)00017-1 · Cited by 911
Loss of p16Ink4a with retention of p19Arf predisposes mice to tumorigenesis
Sharpless, N. E., Bardeesy, N., Lee, K.-H., Carrasco, D., Castrillon, D. H., Aguirre, A. J., Wu, E. A., Horner, J. W., & DePinho, R. A. (2001) · Nature · doi:10.1038/35092592 · Cited by 848
Germline mutations in the p16INK4a binding domain of CDK4 in familial melanoma
Zuo, L., Weger, J., Yang, Q., Goldstein, A. M., Tucker, M. A., Walker, G. J., Hayward, N., & Dracopoli, N. C. (1996) · Nature Genetics · doi:10.1038/ng0196-97 · Cited by 818
Self-citationIncreased Risk of Pancreatic Cancer in Melanoma-Prone Kindreds with p16INK4Mutations
Goldstein, A. M., Fraser, M. C., Struewing, J. P., Hussussian, C. J., Ranade, K., Zametkin, D. P., Fontaine, L. S., Organic, S. M., Dracopoli, N. C., Clark, W. H., et al. (1995) · New England Journal of Medicine · doi:10.1056/nejm199510123331504 · Cited by 622
Loss of p16Ink4a confers susceptibility to metastatic melanoma in mice
Krimpenfort, P., Quon, K. C., Mooi, W. J., Loonstra, A., & Berns, A. (2001) · Nature · doi:10.1038/35092584 · Cited by 568 · cited 2×
“Interestingly, in the study of Krimpenfort et al. (2001), when the p16 null mice were crossed with Arf hemizygotes, 50% of the animals developed melanomas after treatment with the carcinogen 7, 12-dimethylbenz(a)anthracene, compared to 8% of the mice lacking just p16.”
BackgroundGeographical Variation in the Penetrance of CDKN2A Mutations for Melanoma
Bishop, D. T. (2002) · CancerSpectrum Knowledge Environment · doi:10.1093/jnci/94.12.894 · Cited by 509
Palmer, J. S., Duffy, D. L., Box, N. F., Aitken, J. F., O'Gorman, L. E., Green, A. C., Hayward, N. K., Martin, N. G., & Sturm, R. A. (2000) · The American Journal of Human Genetics · doi:10.1086/302711 · Cited by 503 · cited 3×
“Thus, in contrast to the high-penetrance mutations conferred by CDKN2A and CDK4, variants of MC1R have proven to be low-penetrance susceptibility alleles for cutaneous melanoma (Valverde et al., 1996; Palmer et al., 2000; Kennedy et al., 2001).”
BackgroundResultSelf-citationKennedy, C., ter Huurne, J., Berkhout, M., Gruis, N., Bastiaens, M., Bergman, W., Willemze, R., & Bouwes Bavinck, J. N. (2001) · Journal of Investigative Dermatology · doi:10.1046/j.0022-202x.2001.01421.x · Cited by 407
Human pigmentation genes: identification, structure and consequences of polymorphic variation
Sturm, R. A., Teasdale, R. D., & Box, N. F. (2001) · Gene · doi:10.1016/s0378-1119(01)00694-1 · Cited by 390
Evidence for Variable Selective Pressures at MC1R
Harding, R. M., Healy, E., Ray, A. J., Ellis, N. S., Flanagan, N., Todd, C., Dixon, C., Sajantila, A., Jackson, I. J., Birch-Machin, M. A., et al. (2000) · The American Journal of Human Genetics · doi:10.1086/302863 · Cited by 389
Cancer Risks in Two Large Breast Cancer Families Linked to BRCA2 on Chromosome 13q12‐13
Easton, D. F., Steele, L., Fields, P., Ormiston, W., Averill, D., Daly, P. A., McManus, R., Neuhausen, S. L., Ford, D., Wooster, R., et al. (1997) · The American Journal of Human Genetics · doi:10.1086/513891 · Cited by 387
Zhang, Y., & Xiong, Y. (1999) · Molecular Cell · doi:10.1016/s1097-2765(00)80351-2 · Cited by 348
Borg, A., Sandberg, T., Nilsson, K., Johannsson, O., Klinker, M., Masback, A., Westerdahl, J., Olsson, H., & Ingvar, C. (2000) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/92.15.1260 · Cited by 345
Characterization of Melanocyte Stimulating Hormone Receptor Variant Alleles in Twins with Red Hair
Box, N. F., Wyeth, J. R., O'Gorman, L. E., Martin, N. G., & Sturm, R. A. (1997) · Human Molecular Genetics · doi:10.1093/hmg/6.11.1891 · Cited by 340
MC1R Genotype Modifies Risk of Melanoma in Families Segregating CDKN2A Mutations
Box, N. F., Duffy, D. L., Chen, W., Stark, M., Martin, N. G., Sturm, R. A., & Hayward, N. K. (2001) · The American Journal of Human Genetics · doi:10.1086/323412 · Cited by 310
Self-citationThe CDKN2A (p16) Gene and Human Cancer
Foulkes, W. D., Flanders, T. Y., Pollock, P. M., & Hayward, N. K. (1997) · Molecular Medicine · doi:10.1007/bf03401664 · Cited by 292
Self-citationWhelan, A. J., Bartsch, D., & Goodfellow, P. J. (1995) · New England Journal of Medicine · doi:10.1056/nejm199510123331505 · Cited by 280
Mutation of the CDKN2A 5' UTR creates an aberrant initiation codon and predisposes to melanoma
Liu, L., Dilworth, D., Gao, L., Monzon, J., Summers, A., Lassam, N., & Hogg, D. (1999) · Nature Genetics · doi:10.1038/5082 · Cited by 276
CDKN2A Mutations in Multiple Primary Melanomas
Monzon, J., Liu, L., Brill, H., Goldstein, A. M., Tucker, M. A., From, L., McLaughlin, J., Hogg, D., & Lassam, N. J. (1998) · New England Journal of Medicine · doi:10.1056/nejm199803263381305 · Cited by 264
Bliss, J. M., Ford, D., Swerdlow, A. J., Armstrong, B. K., Cristofolini, M., Elwood, J. M., Green, A., Holly, E. A., Mack, T., Mackie, R. M., et al. (1995) · International Journal of Cancer · doi:10.1002/ijc.2910620402 · Cited by 263
Increasing Incidence of Cutaneous Melanoma in Queensland, Australia
MacLennan, R., Green, A. C., McLeod, G. R. C., & Martin, N. G. (1992) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/84.18.1427 · Cited by 261
Association between functional polymorphism in EGF gene and malignant melanoma
Shahbazi, M., Pravica, V., Nasreen, N., Fakhoury, H., Fryer, A. A., Strange, R. C., Hutchinson, P. E., Osborne, J. E., Lear, J. T., Smith, A. G., et al. (2002) · The Lancet · doi:10.1016/s0140-6736(02)07600-6 · Cited by 258
Lynch, H. T., Brand, R. E., Hogg, D., Deters, C. A., Fusaro, R. M., Lynch, J. F., Liu, L., Knezetic, J., Lassam, N. J., Goggins, M., et al. (2002) · Cancer · doi:10.1002/cncr.10159 · Cited by 222
Glutathione S-transferase M1 and T1 polymorphisms: susceptibility to colon cancer and age of onset
Chenevix-Trench, G., Young, J., Coggan, M., & Board, P. (1995) · Carcinogenesis · doi:10.1093/carcin/16.7.1655 · Cited by 204
CDKN2A Variants in a Population-Based Sample of Queensland Families With Melanoma
Aitken, J., Welch, J., Duffy, D., Milligan, A., Green, A., Martin, N., & Hayward, N. (1999) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/91.5.446 · Cited by 200
Self-citationGenotype-Phenotype Relationships in U.S. Melanoma-Prone Families With CDKN2A and CDK4 Mutations
Goldstein, A. M. (2000) · Journal of the National Cancer Institute · doi:10.1093/jnci/92.12.1006 · Cited by 192
Human pigmentation genetics: the difference is only skin deep
Sturm, R. A., Box, N. F., & Ramsay, M. (1998) · BioEssays · doi:10.1002/(sici)1521-1878(199809)20:9<712::aid-bies4>3.0.co;2-i · Cited by 190
A Polymorphism in the Agouti Signaling Protein Gene Is Associated with Human Pigmentation
Kanetsky, P. A., Swoyer, J., Panossian, S., Holmes, R., Guerry, D., & Rebbeck, T. R. (2002) · The American Journal of Human Genetics · doi:10.1086/339076 · Cited by 186
Melanocortin-1 Receptor Variant R151C Modifies Melanoma Risk in Dutch Families with Melanoma
van der Velden, P. A., Sandkuijl, L. A., Bergman, W., Pavel, S., van Mourik, L., Frants, R. R., & Gruis, N. A. (2001) · The American Journal of Human Genetics · doi:10.1086/323411 · Cited by 173
A melanoma-associated germline mutation in exon 1β inactivates p14ARF
Rizos, H., Puig, S., Badenas, C., Malvehy, J., Darmanian, A. P., Jiménez, L., Milà, M., & Kefford, R. F. (2001) · Oncogene · doi:10.1038/sj.onc.1204728 · Cited by 171
Glutathione S-transferase GSTM1 phenotypes and protection against cutaneous tumours
Heagerty, A. H. M., Fitzgerald, D., Smith, A., Bowers, B., Jones, P., Fryer, A., Zhao, L., Alldersea, J., & Strange, R. (1994) · The Lancet · doi:10.1016/s0140-6736(94)91115-0 · Cited by 167
Platz, A., Hansson, J., Månsson‐Brahme, E., Lagerlöf, B., Linder, S., Ringborg, U. K., Lundqvist, E., Sevigny, P., & Inganäs, M. (1997) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/89.10.697 · Cited by 163
ELWOOD, J. M., WHITEHEAD, S. M., DAVISON, J., STEWART, M., & GALT, M. (1990) · International Journal of Epidemiology · doi:10.1093/ije/19.4.801 · Cited by 162
Germline mutation of ARF in a melanoma kindred
Hewitt, C., Wu, C. L., Evans, G., Howell, A., ELLES, R. G., Jordan, R., Sloan, P., Read, A. P., & Thakker, N. (2002) · Human Molecular Genetics · doi:10.1093/hmg/11.11.1273 · Cited by 133
Melanoma in adolescents: A case‐control study of risk factors in Queensland, Australia
Youl, P., Aitken, J. F., Hayward, N. K., Hogg, D., Liu, L., Lassam, N. J., Martin, N. G., & Green, A. C. (2001) · International Journal of Cancer · doi:10.1002/ijc.10117 · Cited by 121
Self-citationGruis, N. A., Sandkuijl, L. A., van der Velden, P. A., Bergman, W., & Frants, R. R. (1995) · Melanoma Research · doi:10.1097/00008390-199506000-00005 · Cited by 110
CDKN2A (p16INK4A) somatic and germline mutations
Smith‐Sørensen, B., & Hovig, E. J. (1996) · Human Mutation · doi:10.1002/(sici)1098-1004(1996)7:4<294::aid-humu2>3.0.co;2-9 · Cited by 97
Kumar, R., Smeds, J., Berggren, P., Straume, O., Rozell, B. L., Akslen, L. A., & Hemminki, K. (2001) · International Journal of Cancer · doi:10.1002/1097-0215(20011120)95:6<388::aid-ijc1069>3.0.co;2-6 · Cited by 96
Characterization of ligurian melanoma families and risk of occurrence of other neoplasia
Ghiorzo, P., Ciotti, P., Mantelli, M., Heouaine, A., Queirolo, P., Rainero, M. L., Ferrari, C., Santi, P. L., Marchi, R. D., Farris, A., et al. (1999) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19991112)83:4<441::aid-ijc2>3.0.co;2-r · Cited by 88
Low Prevalence of Germline CDKN2A and CDK4 Mutations in Patients With Early-Onset Melanoma
Tsao, H., Zhang, X., Kwitkiwski, K., Finkelstein, D. M., Sober, A. J., & Haluska, F. G. (2000) · Archives of Dermatology · doi:10.1001/archderm.136.9.1118 · Cited by 87
CDKN2A Germline Mutations in U.K. Patients with Familial Melanoma and Multiple Primary Melanomas
MacKie, R. M., Andrew, N., Lanyon, W. G., & Connor, J. M. (1998) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.1998.00267.x · Cited by 84
A Single Genetic Origin for the G101W CDKN2A Mutation in 20 Melanoma-Prone Families
Ciotti, P., Struewing, J. P., Mantelli, M., Chompret, A., Avril, M., Santi, P. L., Tucker, M. A., Bianchi‐Scarrà, G., Paillerets, B. B., & Goldstein, A. M. (2000) · The American Journal of Human Genetics · doi:10.1086/303001 · Cited by 83
Petronzelli, F., Sollima, D., Coppola, G., Martini‐Neri, M. E., Neri, G., & Genuardi, M. (2001) · Genes Chromosomes and Cancer · doi:10.1002/gcc.1159 · Cited by 82
G2 phase cell cycle arrest in human skin following UV irradiation
Pavey, S., Russell, T., & Gabrielli, B. (2001) · Oncogene · doi:10.1038/sj.onc.1204707 · Cited by 80 · cited 1×
“…mutations required for cancer to develop, it is interesting to contemplate whether a more direct mechanism may also play a role since UVR has been shown to induce p16 expression in human skin (Pavey et al., 1999), where it is involved in a UVRinduced G2 phase cell-cycle block (Pavey et al., 2001).”
BackgroundA familial syndrome with cutaneous malignant melanoma and cerebral astrocytoma
Kaufman, D. K., Kimmel, D. W., Parisi, J. E., & Michels, V. V. (1993) · Neurology · doi:10.1212/wnl.43.9.1728 · Cited by 80
Ichii‐Jones, F., Yengi, L., Bath, J., Fryer, A. A., Strange, R. C., Lear, J. T., Heagerty, A., Smith, A. G., Hutchinson, P. E., Osborne, J. E., et al. (1998) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.1998.00287.x · Cited by 73
Sporadic multiple primary melanoma cases: CDKN2A germline mutations with a founder effect
Auroy, S., Avril, M., Chompret, A., Pham, D., Goldstein, A. M., Bianchi‐Scarrà, G., Frébourg, T., Joly, P., Spatz, A., Rubino, C., et al. (2001) · Genes Chromosomes and Cancer · doi:10.1002/gcc.1183 · Cited by 72
Familial Tumor Syndrome Associated With a Germline Nonfunctional p16INK4a Allele
Yarbrough, W. G., Aprelikova, O. N., Pei, H., Olshan, A. F., & Liu, E. T. (1996) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/88.20.1489 · Cited by 70
Familial Melanoma and Pancreatic Cancer
Ciotti, P., Strigini, P., & Bianchi-Scarrà, G. (1996) · New England Journal of Medicine · doi:10.1056/nejm199602153340714 · Cited by 68
Germline CDKN2A Mutations in Childhood Melanoma
Whiteman, D. C., Milligan, A., Welch, J., Green, A. C., & Hayward, N. K. (1997) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/89.19.1460 · Cited by 63
Self-citationNew developments in melanoma genetics
Hayward, N. K. (2000) · Current Oncology Reports · doi:10.1007/s11912-000-0022-z · Cited by 57
Self-citationTorre, G. D., Pasini, B., Frigerio, S., Donghi, R., Rovini, D., Delia, D., Peters, G., Huot, T. J. G., Bianchi‐Scarrà, G., Lantieri, F., et al. (2001) · British Journal of Cancer · doi:10.1054/bjoc.2001.1991 · Cited by 56
Phenotype of glutathione S-transferase Mu (GSTM1) and susceptibility to malignant melanoma
and the MMM group, Lafuente, A., Molina, R., et al. (1995) · British Journal of Cancer · doi:10.1038/bjc.1995.332 · Cited by 55
Sun, S. B., Pollock, P. M., Liu, L., Karimi, S., Jothy, S., Milner, B. J., Renwick, A., Lassam, N. J., Hayward, N. K., Hogg, D., et al. (1997) · International Journal of Cancer · Cited by 49
Self-citationHashemi, J., Bendahl, P., Sandberg, T., Platz, A., Linder, S. T., Stierner, U. K., Olsson, H. L., Ingvar, C., Hansson, J., & Borg, Å. (2001) · Genes Chromosomes and Cancer · doi:10.1002/gcc.1124 · Cited by 47
A common founder for the V126D CDKN2A mutation in seven North American melanoma-prone families
Goldstein, A. M., Liu, L., Shennan, M. G., Hogg, D., Tucker, M. A., & Struewing, J. P. (2001) · British Journal of Cancer · doi:10.1054/bjoc.2001.1944 · Cited by 30
Shanley, S., Chenevix‐Trench, G., Palmer, J. M., et al. (1995) · Carcinogenesis · doi:10.1093/carcin/16.8.2003 · Cited by 29
Two p16 (CDKN2A) germline mutations in 30 Israeli melanoma families
Yakobson, E., Shemesh, P., Azizi, E., Winkler, E., Lassam, N. J., Hogg, D., Brookes, S., Peters, G. G., Lotem, M., Zlotogorski, A., et al. (2000) · European Journal of Human Genetics · doi:10.1038/sj.ejhg.5200505 · Cited by 27
CDKN2A novel mutation in a patient from a melanoma-prone family
Grammatico, P., Binni, F., Eibenschutz, L., Bernardo, C. D., Grammatico, B., Rinaldi, R., Simone, P. D., & Catricalà, C. (2001) · Melanoma Research · doi:10.1097/00008390-200110000-00002 · Cited by 4
(1998) · Pure Amsterdam UMC · doi:10.1002/(sici)1098-1004(1998)12:1 · Cited by 1
(1998) · doi:10.1002/(sici)1098-1004(1998)11:6
(2000) · doi:10.1002/(sici)1098-2264(200004)27:4
Cited by
G-protein-coupled receptors and cancer
Dorsam, R. T., & Gutkind, J. S. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2069 · Cited by 1,388
Melanoma biology and new targeted therapy
Gray-Schopfer, V., Wellbrock, C., & Marais, R. (2007) · Nature · doi:10.1038/nature05661 · Cited by 1,371
BrafV600E cooperates with Pten loss to induce metastatic melanoma
Dankort, D., Curley, D. P., Cartlidge, R. A., Nelson, B., Karnezis, A. N., Damsky Jr, W. E., You, M. J., DePinho, R. A., McMahon, M., & Bosenberg, M. (2009) · Nature Genetics · doi:10.1038/ng.356 · Cited by 1,189
Pasmant, E., Laurendeau, I., Héron, D., Vidaud, M., Vidaud, D., & Bièche, I. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-2004 · Cited by 618
A census of amplified and overexpressed human cancer genes
Santarius, T., Shipley, J., Brewer, D., Stratton, M. R., & Cooper, C. S. (2010) · Nature Reviews Cancer · doi:10.1038/nrc2771 · Cited by 482
Metadata
- Authors
- Hayward, N. K.
- Venue
- Oncogene
- Published
- 2003-05-19
- Volume
- 22
- Issue
- 20
- Pages
- 3053-3062
- ISSN
- 0950-9232 (ISSN-L)
- 1476-5594
- OpenAlex
- W2008144998
- Cited by
- 321
- References
- 64
- FWCI
- 10.24
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.